GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 53 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,057 | -44.8% | 52,940 | -10.7% | 0.00% | -100.0% |
| Q1 2023 | $164,876 | -43.1% | 59,308 | -15.6% | 0.00% | 0.0% |
| Q1 2022 | $290,000 | -66.2% | 70,284 | +5.4% | 0.00% | -50.0% |
| Q4 2021 | $858,000 | +126.4% | 66,705 | +90.3% | 0.00% | +100.0% |
| Q3 2021 | $379,000 | +50.4% | 35,049 | +27.1% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | -6.7% | 27,566 | -3.9% | 0.00% | -50.0% |
| Q1 2021 | $270,000 | +112.6% | 28,678 | -10.9% | 0.00% | +100.0% |
| Q4 2020 | $127,000 | -72.0% | 32,172 | -53.0% | 0.00% | -85.7% |
| Q2 2020 | $454,000 | +171.9% | 68,410 | +137.9% | 0.01% | +75.0% |
| Q1 2020 | $167,000 | +5.0% | 28,758 | +140.8% | 0.00% | +100.0% |
| Q1 2019 | $159,000 | -64.2% | 11,942 | -58.4% | 0.00% | -60.0% |
| Q4 2018 | $444,000 | – | 28,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |